Abstract
Objective: To evaluate the impact of body mass index (BMI) on the outcomes of percutaneous nephrolithotomy (PCNL) in the flank-free modified supine position. Patients and Methods: A prospective study was carried out in the urology department during the period from May 2015 to October 2019 on 464 patients admitted for PCNL. The patients were divided into 4 matched groups according to their BMI: group A, normal weight with 18.5 ≤ BMI <25 kg/m2; group B, overweight with 25 ≤ BMI <30 kg/m2; group C, obese with 30 ≤ BMI <40 kg/m2; and group D, morbid obesity with BMI ≥40 kg/m2. All operative data as well as postoperative outcomes are recorded and compared to each other. Results: The 4 studied groups were matched regarding age. The comorbidities were slightly higher in groups C and D. The operative time and fluoroscopy time were slightly high in obese and morbid obese groups but with no significant difference. The rate of complications either major or minor was comparable in all groups. No significant difference was seen among all groups regarding hemoglobin loss, stone-free rate, hospital stay, and need for auxiliary procedures. Conclusions: The outcome of PCNL in flank-free modified supine position is not affected by changes in BMI. The procedure can be performed in obese and morbid obese patients safely with results similar to and comparable to nonobese patients.
References
1.
Flancbaum
L
, Choban
PS
. Surgical implications of obesity
. Annu Rev Med
. 1998
;49
:215
–34
. .2.
WHO Obesity: preventing and managing the global epidemic. Report of a WHO consultation
. World Health Organ Tech Rep Ser
. 2000
;894
(1–253
):i
–xii
.3.
World Health Organization
; 2017
. Obesity and Overweight. Fact sheet No. 311 Switzerland
.4.
Afshin
A
, Afshin
A
, Forouzanfar
MH
, Reitsma
MB
, Sur
P
, Estep
K
, et al. Health effects of overweight and obesity in 195 countries over 25 years
. N Engl J Med
. 2018
;377
(1
):13
–27
. .5.
Calvert
RC
, Burgess
NA
. Urolithiasis and obesity: metabolic and technical considerations
. Curr Opin Urol
. 2005
;15
(2
):113
–7
. .6.
Mayhew
D
, Mendonca
V
, Murthy
BVS
. A review of ASA physical status: historical perspectives and modern developments
. Anaesthesia
. 2019
;74
(3
):373
–9
. .7.
Mezentsev
VA
. Extracorporeal shock wave lithotripsy in the treatment of renal pelvicalyceal stones in morbidly obese patients
. Int Braz J Urol
. 2005
;31
(2
):105
–10
. .8.
Javanmard
B
, Razaghi
MR
, Ansari Jafari
A
, Mazloomfard
MM
. Flexible ureterorenoscopy versus extracorporeal shock wave lithotripsy for the treatment of renal pelvis stones of 10–20 mm in obese patients
. J Lasers Med Sci
. 2015
;6
(4
):162
–6
. .9.
Manohar
T
, Jain
P
, Desai
M
. Supine percutaneous nephrolithotomy: effective approach to high-risk and morbidly obese patients
. J Endourol
. 2007
;21
(1
):44
–9
. .10.
Skolarikos
A
, Alivizatos
G
, de la Rosette
JJ
. Percutaneous nephrolithotomy and its legacy
. Eur Urol
. 2005
;47
(1
):22
–8
. .11.
Pareek
G
, Hedican
SP
, Lee
FT
Jr, Nakada
SY
. Shock wave lithotripsy success determined by skin-to-stone distance on computed tomography
. Urology
. 2005 Nov
;66
(5
):941
–4
. .12.
Desoky
EA
, Allam
MN
, Ammar
MK
, Abdelwahab
KM
, Elsaid
DA
, Fawzi
AM
, et al. Flank free modified supine position: a new modification for supine percutaneous nephrolithotomy
. Arab J Urol
. 2012
;10
(2
):143
–8
. .13.
Desoky
EAE
, ElSayed
ER
, Eliwa
A
, Sleem
M
, Shabana
W
, Dawood
T
, et al. Flank-free modified supine percutaneous nephrolithotomy in pediatric age group
. Urology
. 2015
;85
(5
):1162
–5
.14.
IBM Corp
. IBM SPSS Statistics for Windows, Version 20.0
. Armonk, NY
: IBM Corp.
; 2011
.15.
Finucane
MM
, Stevens
GA
, Cowan
MJ
. National, regional and global trends in body-mass index since 1980: systematic analysis of health examinations surveys and epidemiological studies with 960 country-years and 9.1 million participants
. Lancet
. 2011
;377
:557
–67
.16.
Choban
PS
, Flancbaum
L
. The impact of obesity on surgical outcomes: a review
. J Am Coll Surg
. 1997
;185
(6
):593
–603
.17.
Neligan
PJ
. Metabolic syndrome: anesthesia for morbid obesity
. Curr Opin Anaesthesiol
. 2010
;23
(3
):375
–83
. .18.
Asplin
JR
. Obesity and urolithiasis
. Adv Chronic Kidney Dis
. 2009
;16
(1
):11
–20
. .19.
Thomas
R
, Cass
AS
. Extracorporeal shock wave lithotripsy in morbidly obese patients
. J Urol
. 1993
;150
(1
):30
–2
. .20.
Dash
A
, Schuster
TG
, Hollenbeck
BK
, Faerber
GJ
, Wolf
JS
Jr. Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone-matched comparison
. Urology
. 2002 Sep
;60
(3
):393
–7
. .21.
Preminger
GM
, Assimos
DG
, Lingeman
JE
, Nakada
SY
, Pearle
MS
, Wolf
JS
Jr, et al. AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations
. J Urol
. 2005
;173
:1991
–2000
.22.
Fuller
A
, Razvi
H
, Denstedt
JD
, Nott
L
, Pearle
M
, Cauda
F
, et al. The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome
. J Urol
. 2012
;188
:138
–44
.23.
Koo
BC
, Burtt
G
, Burgess
NA
. Percutaneous stone surgery in the obese: outcome stratified according to body mass index
. BJU Int
. 2004
;93
:1296
–9
.24.
Faerber
GJ
, Goh
M
. Percutaneous nephrolithotripsy in the morbidly obese patient
. Tech Urol
. 1997
;3
(2
):89
–95
.25.
Pearle
MS
, Nakada
SY
, Womack
JS
, Kryger
JV
. Outcomes of contemporary percutaneous nephrostolithotomy in morbidly obese patients
. J Urol
. 1998
;160
(3 Pt 1
):669
–73
. .26.
El-Assmy
AM
, Shokeir
AA
, El-Nahas
AR
, Shoma
AM
, Eraky
I
, El-Kenawy
MR
, et al. Outcome of percutaneous nephrolithotomy: effect of body mass index
. Eur Urol
. 2007
;52
(1
):199
–204
. .27.
Bagrodia
A
, Gupta
A
, Raman
JD
, Bensalah
K
, Pearle
MS
, Lotan
Y
. Impact of body mass index on cost and clinical outcomes after percutaneous nephrostolithotomy
. Urology
. 2008 Oct
;72
(4
):756
–60
. .28.
Alyami
FA
, Skinner
TA
, Norman
RW
. Impact of body mass index on clinical outcomes associated with percutaneous nephrolithotomy
. Can Urol Assoc J
. 2013
;7
(3–4
):E197
–201
. .29.
Jin
W
, Song
Y
, Fei
X
. Does body mass index impact the outcomes of ultrasound-guided percutaneous nephrolithotomy?
Urol Int
. 2019
;103
(2
):149
–55
. .30.
Zhou
X
, Sun
X
, Chen
X
, Gong
X
, Yang
Y
, Chen
C
, et al. Effect of obesity on outcomes of percutaneous nephrolithotomy in renal stone management: a systematic review and meta-analysis
. Urol Int
. 2017
;98
(4
):382
–90
. .© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
